Community Medicine (PSM) · Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera)

As per NVBDCP guidelines, a patient with slide-positive uncomplicated falciparum malaria in a general population area receives artesunate plus sulfadoxine-pyrimethamine. What additional antimalarial is given to destroy gametocytes and reduce transmission?

  • A Quinine 10 mg/kg three times daily for 7 days
  • B Artemether-lumefantrine for 3 days after ACT completion
  • C Chloroquine 25 mg/kg over 3 days
  • D Single dose primaquine 0.75 mg/kg on day 2
Correct answer: D. Single dose primaquine 0.75 mg/kg on day 2

Explanation

The national drug policy adds a single dose of primaquine 0.75 mg/kg on day 2 as a gametocytocide for falciparum malaria, rendering gametocytes non-infective to mosquitoes. Quinine and chloroquine are no longer first-line for uncomplicated falciparum due to resistance. Artemether-lumefantrine is reserved for treatment failure or specific situations, not routinely added after ACT.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs

See all Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs →